Astrotech (NASDAQ:ASTC – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “strong sell” rating to a “sell” rating in a report issued on Sunday.
Separately, Weiss Ratings raised Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, May 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.
View Our Latest Stock Analysis on Astrotech
Astrotech Price Performance
Astrotech (NASDAQ:ASTC – Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. The firm had revenue of $0.34 million during the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%.
Hedge Funds Weigh In On Astrotech
A number of institutional investors have recently modified their holdings of the stock. J. Safra Sarasin Holding AG bought a new position in Astrotech in the 1st quarter worth approximately $140,000. DRW Securities LLC boosted its position in Astrotech by 168.5% in the 4th quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after buying an additional 19,747 shares during the last quarter. Finally, Susquehanna International Group LLP acquired a new stake in shares of Astrotech in the 3rd quarter valued at $66,000. 24.35% of the stock is owned by institutional investors.
About Astrotech
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Recommended Stories
- Five stocks we like better than Astrotech
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
